Xconomy National

• Home
• Boston
• Detroit
• New York
• San Diego
• San Francisco
• Seattle
• Cleantech
• Health IT
• Life Sciences
• Startups
• Subscribe for Free

Matthew Scholz

Matthew Scholz is the CEO of Immusoft, a (currently) Seattle based biotech startup that is commercializing technology to program the human immune system.

Recent posts and comments

• Seattle Needs an “Incubator” Culture

  If Seattle is to occupy a future place of dominance in the biotech world, it must foster more of an “incubator” culture. There is a “valley of death” between the well-funded labs... Read more »

Page 1 of 1

    

Underwriters and Partners

Xconomy Events

Xconomy Forum: Mobile Madness 2012—Total Mobility

Register or Learn More

Connect with Xconomy

• 
• 
• 
• 
• 

Xconomy’s Most Popular

1. The 10 Social News Apps You Need to Try
2. 7 Lessons from TechStars’ David Cohen on Building a Startup Culture
3. Q4 Venture Deals, Dollars Stayed Strong, Making 2011 Best in a Decade
4. With TV App, Dijit Hopes to Ride Out the Coming Apple Revolution in TV
5. 10 Apps & Sites That Bring Back the Joy of Reading

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now

• Home
• Privacy/DMCA
• About
• Contact Us
• Archives
• Advertise
• RSS

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.